Home › Fabry Disease › Ohio
Fabry Disease clinical trials in Ohio
4 studies for Fabry Disease are looking for participants at sites in Ohio.
Cities in Ohio
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
- Children's Hospital Medical Center, Cincinnati
RecruitingPhase 1/2
Ages 18 to 65 · Men · Updated Sep 24, 2026 · NCT06270316A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Sep 1, 2026 · NCT06904261A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 2/3
Ages 2 to 17 · All sexes · Updated Aug 10, 2026 · NCT06328608Fabry Disease Registry & Pregnancy Sub-registry
- Cincinnati Children's Hospital Medical Center (Cincinnati Children's Hospital)- Site Number : 840033, Cincinnati
- University Hospitals Cleveland Medical Center- Site Number : 840119, Cleveland
- Cleveland Clinic - Cleveland- Site Number : 840048, Cleveland
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Jun 23, 2026 · NCT00196742From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.